Amoeba SA Total Assets
Amoeba SA total assets. Based on the latest financial reports, Amoeba SA (ALMIB) holds total assets worth €10.13 Million EUR (≈ $11.85 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ALMIB stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Amoeba SA (2011–2025)
Total assets of Amoeba SA from 2011 to 2025. This chart illustrates how Amoeba SA's total assets have evolved over time, based on quarterly financial data. See ALMIB stock price and chart for real-time trading data and today's change.
Amoeba SA - Asset Composition Analysis
Amoeba SA Total Assets Breakdown (December 2025)
Amoeba SA total assets breakdown as of December 2025. Amoeba SA's total assets of €10.13 Million consist of 66.2% current assets and 33.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 46.6% |
| Accounts Receivable | €1.21 Million | 11.9% |
| Inventory | €590.48K | 5.8% |
| Property, Plant & Equipment | €3.32 Million | 32.7% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Amoeba SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ALMIB current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amoeba SA's current assets represent 66.2% of total assets in 2025, an increase from 41.7% in 2011.
- Cash Position: Cash and equivalents constituted 46.6% of total assets in 2025, up from 27.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 33.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 32.7% of total assets.
Amoeba SA Competitors by Total Assets
Key competitors of Amoeba SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hubei Yihua Chemical Industry Co Ltd
SHE:000422
|
China | CN¥47.34 Billion |
|
Shenzhen Noposion Agrochemicals Co Ltd
SHE:002215
|
China | CN¥12.05 Billion |
|
Jiangsu Huachang Chemical Co Ltd
SHE:002274
|
China | CN¥7.81 Billion |
|
Fanli Digital Technology Co Ltd
SHG:600228
|
China | CN¥575.15 Million |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Liuzhou Chemical Industry Co Ltd
SHG:600423
|
China | CN¥618.15 Million |
|
Shandong Sino-Agri United Biotechnology Co Ltd
SHE:003042
|
China | CN¥3.93 Billion |
|
Madras Fertilizers Limited
NSE:MADRASFERT
|
India | Rs23.33 Billion |
Amoeba SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 0.42 | 2.97 |
| Quick Ratio | 0.89 | 0.37 | 2.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-142.34K | €-3.02 Million | €4.12 Million |
Amoeba SA - Advanced Valuation Insights
This section examines the relationship between Amoeba SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.00 |
| Latest Market Cap to Assets Ratio | 2.35 |
| Asset Growth Rate (YoY) | 79.3% |
| Total Assets | €10.13 Million |
| Market Capitalization | $23.83 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Amoeba SA's assets at a significant premium (2.35x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Amoeba SA's assets grew by 79.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Amoeba SA (2011–2025)
The table below shows the annual total assets of Amoeba SA from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €10.13 Million ≈ $11.85 Million |
+79.29% |
| 2024-12-31 | €5.65 Million ≈ $6.61 Million |
-10.11% |
| 2023-12-31 | €6.29 Million ≈ $7.35 Million |
-49.27% |
| 2022-12-31 | €12.39 Million ≈ $14.49 Million |
-14.55% |
| 2021-12-31 | €14.50 Million ≈ $16.95 Million |
+11.00% |
| 2020-12-31 | €13.06 Million ≈ $15.27 Million |
-5.61% |
| 2019-12-31 | €13.84 Million ≈ $16.18 Million |
+99317.53% |
| 2018-12-31 | €13.92K ≈ $16.28K |
-35.49% |
| 2017-12-31 | €21.58K ≈ $25.23K |
-7.43% |
| 2016-12-31 | €23.31K ≈ $27.26K |
+64.93% |
| 2015-12-31 | €14.13K ≈ $16.53K |
-99.75% |
| 2014-12-31 | €5.55 Million ≈ $6.49 Million |
+148.31% |
| 2013-12-31 | €2.24 Million ≈ $2.61 Million |
+30.13% |
| 2012-12-31 | €1.72 Million ≈ $2.01 Million |
+36.50% |
| 2011-12-31 | €1.26 Million ≈ $1.47 Million |
-- |
About Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more